Listen to the Battle Royale, a regular feature in our Supernova premium service where Fool co-founder David Gardner pits two stocks against each other. Which one will emerge victorious?
We're giving you a free sneak peek into this segment that was taped in April 2012.
For more stock ideas, check out our free report "3 Stocks That Will Help You Retire Rich," in which we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.
Max Keeler: Okay, our next pairing is Pacific Biosciences (PACB 6.16%) of California vs. Athena Health (ATHN).
David Gardner: So between Pac Bio and Athena Health, that's a pretty easy one for me. I think that Athena Health is a healthier company with healthier prospects. It isn't hard to say that when we reflect that Pacific Bio Sciences , which I recommended along with my friend, Karl Thiel, I think a year ago, and that same issue, April 2011, NXP (NXPI -1.93%), and Pac Bio came out, and Pac Bio was at fourteen and a half then; it's at about three bucks now, below three.
Max: Mmm.
David Gardner: So it has performed badly as a stock. And I think there are many more questions about Pacific Bio's business than, what was the competitor?
Max: Athena Health.
David Gardner: Athena Health, right. I just think Athena Health is a surer bet. Nothing is a sure bet on the market, but between those two it's easy for me to push Athena H. forward.
Max: Okay.
